A Study to Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and Children

Stopped Bivalent vaccine no longer epidemiologically relevant.

Conditions

• COVID-19

Interventions

• BIOLOGICAL: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
• BIOLOGICAL: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 6 microgram dose
• BIOLOGICAL: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose
• BIOLOGICAL: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 1 microgram dose

Sponsor

BioNTech SE

Collaborators

• [object Object]